One of the listed companies, Beacon Pharmaceuticals PLC discloses its financial reports for the second quarter, (October – December 23).
The company’s earnings per share (EPS) Tk 1.65 paisa in Q2 of the current financial year (October – December 23). EPS was Tk 1.61 paisa during the same period last year. NAV per share was Tk. 27.38 as of December 31, 2023
Share this
